Company profile
CITIUS ONCOLOGY, INC.
NASDAQ:CTORBiotechnology: Pharmaceutical Preparations
Clinical trials (0)
No records yet.
FDA applications (0)
No records yet.
Company profile
No records yet.
No records yet.